Surgery Partners, Inc.
SGRY
$22.80
$0.301.33%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 93.37% | 65.25% | -242.27% | -104.52% | -25.00% |
Total Depreciation and Amortization | 11.02% | 7.08% | -32.47% | 44.25% | 3.26% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -6.38% | -70.44% | 190.39% | -11.88% | 48.86% |
Change in Net Operating Assets | 70.65% | -80.63% | -11.70% | -31.16% | 42.97% |
Cash from Operations | 1,255.00% | -94.61% | 70.86% | -21.26% | 103.44% |
Capital Expenditure | -3.08% | -1.79% | -10.40% | 24.91% | -28.10% |
Sale of Property, Plant, and Equipment | 693.75% | 336.36% | -- | -- | -100.00% |
Cash Acquisitions | 90.91% | 49.77% | -229.32% | 87.33% | -284.62% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 40.69% | -400.00% | -3.57% | 61.11% | 20.00% |
Cash from Investing | 102.75% | 31.60% | -125.20% | 79.68% | -193.74% |
Total Debt Issued | -21.07% | -19.67% | 57.90% | -84.73% | 472.94% |
Total Debt Repaid | -50.96% | 30.03% | -26.30% | 84.18% | -610.15% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 20.28% | -35.23% | -16.46% | 31.83% | -47.04% |
Cash from Financing | -307.28% | -37.08% | 757.53% | -103.85% | 498.11% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 151.74% | -184.28% | 474.70% | -70.67% | 364.49% |